Search results
Results from the WOW.Com Content Network
Bayer AG (English: / ˈ b aɪ. ər /, commonly pronounced / ˈ b eɪ ər /; [3] German:) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Bayer AG began marketing in the United States soon after the company's inception in Germany. In the late 19th century, they began to sell their trademark medication, aspirin . While the name "aspirin" became synonymous with Bayer for over a quarter of a century, the company's patents and trademarks were seized by the United States Office of ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Shares in Bayer dropped as much as 5.7% on Monday after the embattled German company was ordered to pay $2.25 billion in damages, the highest amount yet in its ongoing litigation linked to an ...
FRANKFURT (Reuters) -Bayer beat first-quarter analyst forecasts as it reported a slight drop in adjusted earnings on Tuesday, providing a respite for the CEO's turnaround efforts. The company's ...
Takeda Pharmaceutical: Shire: 62.5 78 Third bid, unanimously rejected by the Shire Board, who concluded that it significantly undervalue the company, its growth prospects as well as pipeline. [24] 10 2016 Bayer AG: Monsanto Company Inc. 62 81 Bayer initially opened negotiations with an offer of $125 per Monsanto share, however management felt ...
In a bid to claw back $2.15 billion, the struggling pharmaceutical giant Bayer CEO is doing away with middle managers and 99% of the company’s 1,362-page corporate handbook, allowing nearly ...